Acro Biomedical (ACBM) 10-K2020 FY Annual report

Filed: 2 Apr 21, 5:04pm

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. sophomore V good

New words: administer, administered, advantage, anniversary, arrangement, attestation, billion, borrowing, calendar, capacity, caption, category, chain, column, consent, counter, COVID, curb, cybersecurity, delinquent, directly, disposable, downturn, economy, embark, equipment, excluding, extend, failure, formal, fulfill, implicit, inability, incentive, incremental, internet, Jumpstart, King, lesser, liable, line, Lltd, maximum, million, minimal, minimum, mix, model, monthly, noncompliance, outbreak, pandemic, PRC, predict, prolonged, quarantine, rapidly, rely, remain, remaining, rental, resale, restricted, ROU, sentence, situation, small, spread, straight, terminate, unaudited, underlying

Removed: Acrology, aquatic, assured, ASU, Ayuveda, bearing, black, blind, body, brown, build, cap, center, Collection, color, Commercial, dark, determinable, discontinued, double, family, FASB, fee, fit, fixed, folk, fruit, ground, guidance, Hawaiian, host, immature, infected, insect, Integrative, international, iv, Jinxia, Journal, larvae, larval, LLP, Local, maturity, medication, medicinal, met, mummifying, mushroom, mycelium, organism, parasitic, Persuasive, pervaded, practical, prepayment, prescription, root, stipe, stroma, surface, testing, waterpark, Xiamen, yellowish, Yongfeng

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

ACBM similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

EXHIBIT 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report of Acro Biomedical Co., Ltd. (the “Company”) on Form 10-K for the year ended December 31, 2020 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Pao-Chi Chu, chief executive officer of the Company, and acting chief financial officer of the Company, certify, pursuant to 18 U.S.C. section 1350 of the Sarbanes-Oxley Act of 2002, that:

	(1)	The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

	(2)	The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: April 2, 2021

By:

/s/ Pao-Chi Chu

Pao-Chi Chu

Chief Executive Officer and Chief Financial Officer

(Principal Executive, Financial and Accounting Officer)

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.